ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

Obesity, Faster Weight Gain, Linked To Poor Prognosis

October 28, 2005

DCE Board Approves Epidemiology Contract Recompetitions

March 17, 1995

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993

In Brief: Senate Subcommittee Recommends $1 .52 Billion

September 25, 1987

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975